![Canakinumab Ilaris](https://www.autoinflammatory.uk/wp-content/uploads/2019/08/Ilaris-800x350.jpg)
NHS Consultation on Canakinumab (Ilaris)
NHS England has launched a 30 day consultation on the use of canakinumab for treating the following periodic fever syndromes: TRAPS, HIDS/MKD and FMF. More info and link to the consultation can be found in this post. Closes 1st Sept 2019.